<DOC>
	<DOCNO>NCT00389103</DOCNO>
	<brief_summary>purpose study assess safety immunogenicity two MVA smallpox vaccine injection healthy adult 18-35 year age history mild moderate Atopic Dermatitis .</brief_summary>
	<brief_title>Safety Study MVA Smallpox Vaccine Subjects With History Atopic Dermatitis ( AD )</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study . subject randomize receive investigational vaccine placebo ratio 3.5:1 , MVA3000 placebo . All subject undergo screen period , treatment/observation period subject receive injection study day 0 study day 28 investigational vaccine placebo . The clinical observation period complete day 56 . A visit occur approximately 3 month second study injection ( study day 118 ) additional blood collection review subject 's health status . Follow-up obtain via telephone contact approximately 6 month end second injection treatment/observation period .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Adults least 18 year old born 1971 previous history smallpox vaccination Subjects must good general health Female subject must pregnant lactating must agree practice birth control course study Subjects must diagnosis AD experienced clinician include history major minor diagnostic criterion At time screening , subject must `` mild moderate '' AD . History evidence prior exposure vaccinia MVA contain product know suspected history immunodeficiency AD Known suspect impairment major organ function Known history diagnosis cardiac disease cerebrovascular disease presence acute , chronic , active exfoliative skin condition AD , open wound , burn . Dementia history seizure Known allergy MVA known component vaccine transfusion blood , organ transplantation , treatment blood product morbid obesity , BMI le equal 18.5 history current drug alcohol abuse ( except nicotine ) within past 6 month history IV drug use history major psychiatric illness except major depression require medical therapy . subject participate another investigational drug vaccine trial within 30 day study day 0</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>